LEXINGTON, Mass., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...
– New clinical trial data highlight potential of an evoked migraine model to test ...
Additional Mircera® volume will provide Vifor Pharma with more flexibility to expand its US ...
